Published in Am J Surg on January 01, 1996
Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice. Am J Physiol Gastrointest Liver Physiol (2009) 1.52
Effect of internal biliary drainage on plasma levels of endotoxin, cytokines, and C-reactive protein in patients with obstructive jaundice. World J Surg (2002) 1.47
NF-kappaB is activated in cholestasis and functions to reduce liver injury. Am J Pathol (2001) 1.12
Regulation and function of trefoil factor family 3 expression in the biliary tree. Am J Pathol (2004) 0.90
Effects of Salvia miltiorrhizae on ICAM-1, TLR4, NF-kappaB and Bax proteins expression in multiple organs of rats with severe acute pancreatitis or obstructive jaundice. Inflammation (2009) 0.89
Pathophysiology of lung injury induced by common bile duct ligation in mice. PLoS One (2014) 0.84
Protective effects of Salvia miltiorrhizae on multiple organs of rats with obstructive jaundice. Mediators Inflamm (2009) 0.79
Dexamethasone pretreatment attenuates lung and kidney injury in cholestatic rats induced by hepatic ischemia/reperfusion. Inflammation (2012) 0.79
Alterations of tumor necrosis factor-alpha and interleukin 6 production and activity of the reticuloendothelial system in experimental obstructive jaundice in rats. HPB (Oxford) (2002) 0.79
Protective effect and mechanisms of radix astragali injection on the intestinal mucosa of rats with obstructive jaundice. Mediators Inflamm (2010) 0.77
Reactive oxygen species and vascular cell adhesion molecule-1 in distant organ failure following bile duct obstruction in mice. Dig Dis Sci (2002) 0.76
Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med (1988) 5.16
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J Exp Med (1989) 4.66
Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A (1992) 3.61
A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci U S A (1991) 3.21
Sepsis syndromes: understanding the role of innate and acquired immunity. Shock (2001) 3.11
Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man. J Immunol (1989) 3.03
Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J Immunol (1997) 2.86
Portal vein embolization: rationale, technique and future prospects. Br J Surg (2001) 2.41
Prognostic factors in carcinoma of the colon and rectum. Am J Surg (1968) 2.25
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol (2001) 2.24
The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest (1990) 2.08
IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol (1991) 2.03
Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Am J Physiol (1989) 1.99
Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol (1995) 1.94
Proinflammatory cytokines, nutritional support, and the cachexia syndrome: interactions and therapeutic options. Cancer (1997) 1.88
Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg (2001) 1.87
Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. FASEB J (1989) 1.82
Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans. Ann Surg (1989) 1.79
Type I IL-1 receptor blockade exacerbates murine listeriosis. J Immunol (1992) 1.78
Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol (2001) 1.77
Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J (2001) 1.73
Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol (1993) 1.73
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys (2002) 1.69
The relationship between visceral ischemia, proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair. Crit Care Med (2000) 1.65
Structural and hormonal alterations in the gastrointestinal tract of parenterally fed rats. Gastroenterology (1975) 1.61
Retroperitoneal sarcoma: the University of Florida experience. J Am Coll Surg (1996) 1.60
Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery (2001) 1.60
Laparoscopy in the staging of pancreatic cancer. Br J Surg (2001) 1.59
Nuclear factor-kappa B is upregulated in colorectal cancer. Surgery (2001) 1.55
Effect of intravenous hyperalimentation on established delayed hypersensitivity in the cancer patient. Ann Surg (1976) 1.53
Cytokine signaling--regulation of the immune response in normal and critically ill states. Crit Care Med (2000) 1.50
Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet (1990) 1.50
Protein dynamics during refeeding of protein-depleted rats: effects of increasing amino acid intake by TPN or enteral continuous feeding. J Nutr (1984) 1.50
Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis. Proc Natl Acad Sci U S A (2001) 1.49
Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci U S A (1990) 1.47
Management of recurrent colorectal cancer: another look at carcinoembryonic antigen-detected recurrence. Dig Dis (1996) 1.46
Central venous catheter vascular erosions. Diagnosis and clinical course. Ann Surg (1989) 1.46
Effects of intravenous IL-8 administration in nonhuman primates. J Immunol (1992) 1.44
Limitations of conventional doses of chemoradiation for unresectable biliary cancer. Int J Radiat Oncol Biol Phys (2002) 1.44
Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Res (1991) 1.44
Role and effect of TNF-alpha in experimental visceral leishmaniasis. J Immunol (1994) 1.43
The effects of sepsis and endotoxemia on gut glutamine metabolism. Ann Surg (1990) 1.41
Correlation between Acute Physiology and Chronic Health Evaluation (APACHE) III score and immunological parameters in critically ill patients with sepsis. Br J Surg (1996) 1.41
What is a surgical oncologist? Ann Surg Oncol (1994) 1.40
Squamous cell carcinoma of the anal margin. Oncology (Williston Park) (1996) 1.40
Hyperalimentation in cancer. CA Cancer J Clin (1989) 1.39
LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-alpha and the TNF-p55 receptor. Am J Physiol Regul Integr Comp Physiol (2000) 1.39
Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6. Eur J Immunol (1993) 1.39
Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis. J Immunol (1998) 1.38
Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation (2000) 1.37
The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection. J Surg Res (1990) 1.36
Interleukin 1: an important mediator of host resistance against Pneumocystis carinii. J Exp Med (1992) 1.36
Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg (1988) 1.34
Prognosis and treatment in minimal breast cancer. Am J Surg (1977) 1.32
The biologic characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet (1990) 1.32
Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol (2000) 1.31
Effect of ibuprofen on fever and metabolic changes induced by continuous infusion of leukocytic pyrogen (interleukin 1) or endotoxin. Infect Immun (1983) 1.30
Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg (2001) 1.29
Effect of cholecystokinin on myoelectric activity of small bowel of the dog. Am J Physiol (1977) 1.27
Carcinoma of the stomach in the young adult. Surg Gynecol Obstet (1980) 1.27
Influence of progressive tumor growth on glutamine metabolism in skeletal muscle and kidney. Ann Surg (1993) 1.24
Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol (2007) 1.22
Intravenous hyperalimentation as an adjunct to cancer chemotherapy. Am J Surg (1975) 1.22
Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus. J Clin Invest (1999) 1.21
Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. J Perinatol (2008) 1.21
Biological measures for the formulation of a hospital prognostic index. Am J Clin Nutr (1981) 1.19
Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J Exp Med (1995) 1.19
The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor. Clin Immunol (2000) 1.19
Effect of vagotomy on electrical activity of the small intestine of the dog. Am J Physiol (1975) 1.18
Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. Shock (1995) 1.18
Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligand. Am J Physiol Regul Integr Comp Physiol (2000) 1.17
Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia. Clin Physiol (1987) 1.17
Axillary metastases from unknown primary sites. Ann Surg (1973) 1.17
Antibodies chaperone circulating IL-6. Paradoxical effects of anti-IL-6 "neutralizing" antibodies in vivo. J Immunol (1993) 1.15
Oral glutamine accelerates healing of the small intestine and improves outcome after whole abdominal radiation. Arch Surg (1990) 1.15
The use of hyperalimentation in patients with potential sepsis. Surg Gynecol Obstet (1974) 1.14
Intravenous hyperalimentation. Effect on delayed cutaneous hypersensitivity in cancer patients. Ann Surg (1980) 1.10
Response to immunized, parenterally nourished rats to challenge infection with the nematode, Trichinella spiralis. J Nutr (1976) 1.10
Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis. Blood (1999) 1.10
Arterial therapy of hepatic colorectal metastases. Br J Surg (1996) 1.10
Effects of various diets on colonic growth in rats. Gastroenterology (1979) 1.09
Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis. Arch Surg (1994) 1.09
Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood (1996) 1.09
Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study. Regul Pept (2001) 1.08
Metalloproteinase inhibitors and wound healing: a novel enhancer of wound strength. Surgery (1998) 1.07
Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood (1992) 1.07
Liver dysfunction following small-bowel bypass for obesity. Nonoperative treatment of fatty metamorphosis with parenteral hyperalimentation. JAMA (1976) 1.07
An altered response by peripheral leukocytes to synthesize or release leukocyte endogenous mediator in critically ill, protein-malnourished patients. J Lab Clin Med (1982) 1.07
Action of gastrin on gastrointestinal structure and function. Gastroenterology (1975) 1.07
Leukocyte endogenous mediator alters protein dynamics in rats. Metabolism (1983) 1.07
Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J Immunol (1997) 1.06
Glutamine-enriched diets support muscle glutamine metabolism without stimulating tumor growth. J Surg Res (1990) 1.06
Nutrition as an adjunct to cancer treatment in the adult. Cancer Res (1977) 1.06